Prevalence of chronic obstructive pulmonary disease in Cyprus: A population-based study

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 3, 2012, Pages 259-267

  Zachariades, Andreas G ^a   Zachariadou, Theodora ^b   Adamide, Tonia ^c   Anagnostopoulou, Urania ^a   Georgiou, Andreas ^c   Gourgoulianis, Konstantinos I ^d  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b Engomi Primary Heath Care Centre   (Greece)

^c Nicosia General Hospital   (Greece)

^d UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Cyprus; Epidemiology; OPD; Prevalence; Smoking; Spirometry

Indexed keywords

SALBUTAMOL;

ADULT; AGED; AIR POLLUTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CYPRUS; DISEASE SEVERITY; EDUCATIONAL STATUS; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RURAL AREA; SMOKING; SPIROMETRY; URBAN AREA;

AGED; ALBUTEROL; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; CYPRUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RURAL POPULATION; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; URBAN POPULATION;

EID: 84862097635     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.650242     Document Type: Article

References (46)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease - updated 2008. http://www.goldcopd.org/Guidelines/guideline-global- strategy-fordiagnosis%2c-management%2c-and-prevention-of-copd-%282008- edition%29.html
2. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006 ; 27 : 188-207.
3. Lopez AD, Shibuya K, Rao C et al., Chronic obstructive pulmonary disease: Current burden and future projections. Eur Respir J 2006 ; 27 : 397-412.
4. Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: Systematic review. BMC Med 2011 ; 9 : 7 Accessed at http://www.biomedcentral.com/17741-7015/9/7.
5. Mannino DM, Buist AS. Global burden of copd: Risk factors, prevalence, and future trends. Lancet 2007 ; 370 : 765-773.
6. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of copd: Systematic review and meta-analysis. Eur Respir J 2006 ; 28 : 523-532.
7. Nowak D, Berger K, Lippert B, Kilgert K, Caeser M, Sandtmann R. Epidemiology and health economics of copd across Europe. A critical analysis. Treat Respir Med 2005 ; 4 ( 6 ): 381-395.
8. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting copd prevalence estimates: What is the true burden of disease ? Chest 2003 ; 123 : 1684-1692.
9. Sinn DD, Stafi nski T, Ng YC, Bell NR, Jacobs P. The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med 2002 ; 165 : 704-707.
10. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000 ; 160 : 1683-1689.
11. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002 ; 166 : 675-679.
12. Statistical Service of the Republic of Cyprus. Demographic Report 2007. http://www.mof.gov.cy/mof/cystat/statistics.nsf/index-gr/index-gr?OpenDocument.
13. ATS Statement. Standardization of spirometry - 2005 update. Eur Respir J 2005 ; 26 : 319-338.
14. Statistical Service of Cyprus. European Health Survey 2008. Health Statist 2008 ; II : 7.
15. Tzanakis N, Anagnostopoulou U, Filaditaki V, Christaki P, Siafakas N. Prevalence of copd in Greece. Chest 2004 ; 125 : 892-900.
16. Minas M, Hatzoglou C, Karetsi E, Papaioannou Al, Tanou K, Tsaroucha R, Gogou E, Gourgoulianis KI, Kostikas K. copd prevalence and the diff erences between newly and previously diagnosed copd patients in a spirometry program. Prim Care Respir J 2010 ; 19 : 363-370.
17. Sichletidis L, Tsiotsios I, Gavriilidis A, Chloros D, Kottakis I, Daskalopoulou E, Konstantinidis T. Prevalence of chronic obstructive pulmonary disease and rhinitis in northern Greece. Respiration 2005 ; 72 : 270-277.
18. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, Pehlivan E. Prevalence of copd: First epidemiological study of a large region in Turkey. Eur J Intern Med 2008 ; 19 : 499-504.
19. Roche N, Dalmay F, Perez T, Kuntz C, Vergnenegre A, Neukirch F, Giordanella JP, Huchon G. Impact of chronic airfl ow obstruction in a working population. Eur Respir J 2008 ; 31 : 1227-1233.
20. Pẽa VS, Miravitlles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fernández-Fau L. Geographic variations in prevalence and underdiagnosis of copd: Results of the IBERPOC multicentre epidemiological study. Chest 2000 ; 118 : 981-989.
21. Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, Giuntini C. Prevalence of airways obstruction in a general population: European Respiratory Society vs American thoracic Society defi nition. Chest 2000 ; 117 ( Suppl 2 ): 339-345.
22. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, et al, for the Platino Team. Chronic obstructive pulmonary disease in fi ve Latin American cities (the PLATINO study): A prevalence study. Lancet 2005 ; 366 : 1875-1881.
23. Vollmer WM, Gislason P, Burney P, Enright PL, Gulsvik A, Kocabas A, Buist AS for the BOLD Collaborative Research Group. Comparison of spirometry criteria for the diagnosis of copd: Results from the BOLD study. Eur Respir J 2009 ; 34 : 588-597.
24. Zhong N, Wang C, Yao W, Chen P, Kang J, Shaoguang et al. H Prevalence of chronic obstructive pulmonary disease in China: A large population-based survey. Am J Respir Crit Care Med 2007 ; 176 : 753-760.
25. Lindberg A, Bjerg-Backlund A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and under-diagnosis of copd by disease severity and the attributable fraction of smoking: Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006 ; 100 : 264-272.
26. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: A community study. Th orax 2005 ; 60 : 842-847.
27. Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender and smoking habits. Respiration 2005 ; 72 : 471-479.
28. Tsoumakidou M, Tzanakis, N, Voulgaraki O, et al. Is there any correlation between the ATS, BTS, ERS, and GOLD copd'-rfsti severity scales and the frequency of hospital admissions? Respir Med 2004 ; 98 : 178-183.
29. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with copd: A summary of the ATS/ERS position paper. Eur Respir J 2004 ; 23 : 932-946.
30. British thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Th orax 1997 ; 52 ( suppl 5 ): 1S - 28S.
31. Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J. Prevalence of copd in Spain: Impact of undiagnosed copd on quality of life and daily life activities. Th orax 2009 ; 64 : 863-868.
32. Becklake MR. Occupational exposures: Evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989 ; 14 : S85-S91.
33. Stang P, Lydick E, Silberman C, et al. The prevalence of copd: Using smoking rates to estimates disease frequency in the general population. Chest 2000 ; 117 ( Suppl 2 ): 349S - 354S.
34. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E. International variation in the prevalence of copd (the BOLD Study): A population-based prevalence study. Lancet 2007 ; 370 : 741-750.
35. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Th orax 2006 ; 61 : 1043-1047.
36. Buff els J, Degryse J, Heyrman J, Decramer M. Office spirometry signifi cantly improves early detection of copd in genarl practice: The DIDASCO Study. Chest 2004 ; 125 : 1394-1399.
37. Zielinski J, Bednarek M, Górecka D, Viegi G, Hurd SS, Fukuchi Y, Increasing copd awareness. Eur Respir J 2006 ; 27 : 833.
38. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: Two approximations from the United States and the United Kingdom. Chest 2003 ; 124 : 474-481.
39. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. copd and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005 ; 128 : 2068-2075.
40. Van Manen JG, Bindels PJ, IJzermans CJ, van der Zee JS, Bottema BJ, Shade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001 ; 54 : 287-293.
41. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease: A case control study in a health maintenance organization. Arch Intern Med 2000 ; 160 : 2653-2658.
42. Walsh JW, Th omashow BM. copd and co-morbidities: Results of copd Foundation national survey. Paper presented at "COPD and co-morbidities: Treating the whole patient," ATS 2006 San Diego International Conference; 2006 May 19-24 ; San Diego, CA.
43. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of co-morbidities in newly diagnosed copd and asthma in primary care. Chest 2005 ; 128 : 2099-2107.
44. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airfl ow limitation and reduced transfer coeffi cient in patients with asthma after 26 years of follow up. Th orax 2003 ; 58 : 322-327.
45. Silva GE, Sherill DL, Guerra S, Barbee RA. Asthma as a risk factor for copd in a longitudinal study. Chest 2004 ; 126 : 59 - 65.
46. Guerra S. Overlap of asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2004 ; 11 : 7-13.